Cranial Guidance Software Market to Register a Steady CAGR of 7.7% Between 2023 – 2031 | Growth Plus Reports


Newark, New Castle, USA, April 20, 2023 (GLOBE NEWSWIRE) — The global Cranial Guidance Software Market is projected to register a revenue CAGR of 7.7% from 2023 to 2031, according to the latest evaluation by Growth Plus Reports. The study examines the best impactful strategies, macroeconomic conditions, trends and prospects, competitive environments, changing market dynamics, market size, data and projections, and key investment areas.

Key Takeaways:

  • The increasing prevalence of cranial diseases will drive the demand for cranial guidance software during the forecast period.


  • Increasing government support will encourage market revenue growth.
  • North America will dominate the global market.

Request a Free Sample of the Research Report:

                        Cranial Guidance Software Market Scope

Report Attribute Details
Growth Rate CAGR of 7.7% from 2023 to 2031
Base Year for Estimation 2022
Forecast Period 2023 to 2031
Historical Year 2021
Segments Covered Deployment, End User, and Region
Regional Scope North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Market Drivers
The increased prevalence of brain tumors and other cranial diseases are the primary factors driving the revenue growth of the global cranial guidance software market. Additionally, the growing geriatric population, environmental pollutant exposure, and advancements in medical imaging technology contribute to market revenue growth. Furthermore, increasing government initiatives to encourage the use of image-guided surgery software support the market’s revenue growth.

Market Segmentation
Growth Plus Reports has analyzed the global cranial guidance software market from three perspectives: Deployment, End User, and Region

Deployment Segmentation: Based on the deployment, the global cranial guidance software market is segmented into cloud-based and on premises software. The cloud-based segment dominates the market with the largest revenue share because cloud-based software for cranial guidance can be used from any place with internet connection, making it ideal for practices with many sites or practitioners who need remote access to patient data.

End-User Segmentation: Based on the end-user, the global cranial guidance software market is segmented into hospitals, ambulatory surgery centers, and speciality clinics. The hospital segment dominates the market because hospitals have the specialized equipment needed to perform cranial surgery, and patients choose hospitals for brain treatments because they provide advanced technology and highly qualified and experienced medical professionals for critical cranial surgeries.

Regional Growth Dynamics
Based on the region, the global cranial guidance software market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominates the global cranial guidance software market with the largest revenue share. The considerable revenue share of North America in the global cranial guidance software market can be attributed to the growing prevalence of neurological illnesses and brain tumors, the presence of a sophisticated healthcare system, the increased use of innovative technologies in the healthcare industry, the growing geriatric population, the growing demand for minimally invasive operations, and the growing adoption of cranial guiding software.

Request for Customization –

Competitive Landscape

The following are the top companies in the global cranial guidance software market:

  • Stryker
  • Medtronic plc
  • Brainlab Ag
  • Depuy Synthes (Jhonson & Jhonson Medical Device Company)
  • Renishaw Plc.

The market for cranial guidance software is very competitive and complex. Prominent companies are developing new products and forming strategic alliances to successfully fulfill the growing global demand and maintain a strong market position.

Recent developments:

  • Stryker announced in February 2023 that their Q guidance System with cranial guidance software has acquired 510(k) clearance from the United States Food and Drug Administration. The Q Guidance Software is a cranial surgery planning and intraoperative guiding system based on images.

Table of Content

    1. Market Ecosystem
    2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
    3. Currency Used in the Report
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
    4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2022) 
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
    1. Cloud-based
    2. On Premises
    1. Hospitals
    2. Ambulatory Surgery Centers
    3. Speciality Clinics


Buy this Premium Research Report:


  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
  • Comprehensive quantitative and qualitative insights at segment and sub-segment level
  • Covid 19 impact trends and perspective
  • Granular insights at global/regional/country level
  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
  • Blanket coverage on competitive landscape
  • Winning imperatives
  • Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market


  • Distributor Landscape Assessment
  • Pricing Intelligence
  • Customer Base Assessment
  • Investment & Initiatives Analysis
  • ‘Business Profile’ of Key Players

Schedule a call with our analyst:

Visit our report store at –

Browse Latest Healthcare Related Reports:

Dry Powder Inhalers Market by Product Type (Single Dose Dry Powder Inhaler, Multi Dose Dry Powder Inhaler), Application (Chronic Obstructive Pulmonary Disease, Pulmonary Arterial Hypertension), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Drug Stores)– Global Outlook & Forecast 2023-2031

Diabetic Neuropathy Market by Disorder (Peripheral Neuropathy, Autonomic Neuropathy), Drug Class (Analgesic, Antidepressant) – Global Outlook and Forecast 2023-2031

Hypertension Drugs Market by Drug Class (Beta Blockers, Diuretics), Distribution Channel (Hospital Pharmacies, Online Pharmacies) – Global Outlook & Forecast 2023-2031

Operating Room Integration Market by Component (Software, Services), Application General Surgery, Orthopedic Surgery), Device Type (Audio-Video Management System, Display System), End User (Hospitals, Ambulatory Surgery Centers) – Global Outlook & Forecast 2023-2031

Cardiology Stem Cells Market by Types of Cells (Embryonic Stem Cells, Cord Blood Stem Cells, and Amniotic Fluid Stem Cells), Source (Autologous, Allogenic), Application (Heart Failure, Myocardial Infarction), End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes) – Global Outlook and Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.

CONTACT: Manan Sethi Director, Market Insights Email: [email protected] 256 Chapman Road STE 105-4, Newark, New Castle - 19702, USA Phone no: +1 888 550 5009 Web:

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. takes no editorial responsibility for the same.